Alkermes Investigational Site

Oakland, California 94612

0 studies enrolling now · 11 studies all time

What they study most

Alcohol Use Disorder, Bipolar I Disorder, Major Depressive Disorder, Schizoaffective Disorder, Schizophrenia, Schizophreniform Disorder

Studies at this site

• Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 — Completed
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study — Completed
• A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) — Completed
• An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) — Completed
• A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder — Completed